(Q47725947)

English

Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients

scientific article published in May 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9694610

Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9694610

1 reference

based on heuristic

inferred from title

author name string

Chung HC

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9694610

Rha SY

2

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9694610

Park JO

3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9694610

Yoo NC

4

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9694610

Kim JH

5

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9694610

Roh JK

6

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9694610

Min JS

7

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9694610

Lee KS

8

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9694610

Kim BS

9

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9694610

Kim JJ

10

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9694610

language of work or name

0 references

publication date

1 May 1998

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9694610

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9694610

49

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9694610

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9694610

41-50

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9694610

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005997421733

21 January 2018

A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005997421733

21 January 2018

Plasminogen activator inhibitors: hormonally regulated serpins

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005997421733

21 January 2018

Plasminogen activator inhibitor-1 and prognosis in primary breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005997421733

21 January 2018

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005997421733

21 January 2018

Urokinase-type plasminogen activator and its inhibitor PAI-1: predictors of poor response to tamoxifen therapy in recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005997421733

21 January 2018

Menstrual influence on surgical cure of breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005997421733

21 January 2018

Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005997421733

21 January 2018

Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005997421733

7 January 2021

based on heuristic

inferred from DOI database lookup

Antigen levels of urokinase plasminogen activator and its receptor at the tumor-host interface of colorectal adenocarcinomas are related to tumor aggressiveness

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005997421733

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasminogen activators and plasminogen activator inhibitors in blood and tumour fluids of patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005997421733

7 January 2021

based on heuristic

inferred from DOI database lookup

Urokinase plasminogen activator induces angiogenesis and tumor vessel invasion in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005997421733

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential expression and localization of integrins and CD44 in the membrane domains of human uterine epithelial cells during the menstrual cycle

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005997421733

7 January 2021

based on heuristic

inferred from DOI database lookup

Timing of surgery during the menstrual cycle for breast cancer: possible role of growth factors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005997421733

7 January 2021

based on heuristic

inferred from DOI database lookup

Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005997421733

7 January 2021

based on heuristic

inferred from DOI database lookup

Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005997421733

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1005997421733

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9694610

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9694610

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47725947&oldid=2208784752"